Simulations Plus

Company that develops and markets software for drug discovery and development, primarily serving the pharmaceutical and biotechnology industries. It specializes in creating modeling and simulation software for absorption, distribution, metabolism, excretion, and toxicity (ADMET) processes, which aids in predicting the behavior of drugs within the human body. The primary users of Simulations Plus' software are pharmaceutical companies, biotechnology firms, and research institutions focused on drug development and safety assessment.